|
Market Closed -
Nasdaq
16:00:00 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 8.050 USD | -0.25% |
|
-4.17% | +3.21% |
| 10-05 | Biocryst Pharmaceuticals, Inc. Announces Formation of Scientific Advisory Board | CI |
| 10-05 | BioCryst Pharmaceuticals Forms Scientific Advisory Board as R&D Model Evolves | MT |
Chart calendar BioCryst Pharmaceuticals, Inc.
Upcoming events on BioCryst Pharmaceuticals, Inc.
No events available
Past events on BioCryst Pharmaceuticals, Inc.
| 2026-08-05 | Earnings release - Q2 2026 | |
| 2026-08-05 | Earnings presentation | 08:30 |
| 2026-06-11 | Annual General Meeting | 10:00 |
| 2026-05-06 | Earnings release - Q1 2026 | |
| 2026-05-06 | Earnings presentation | 08:30 |
| 2026-02-26 | Earnings release - Q4 2025 | |
| 2026-02-26 | Earnings presentation | 08:30 |
| 2025-11-03 | Earnings presentation | 08:30 |
| 2025-11-03 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 331 328 0.92% | 451 449 0.32% | 875 620 41.06% | 710 | 739 | 834 |
|
EBITDA Million USD | Released Forecast Spread | -102 -101 -1% | -1,30 18,8 -106.89% | 342 96,0 256.65% | -174 | 196 | 282 |
|
EBIT Million USD | Released Forecast Spread | -104 -83,5 -24.27% | -2,54 12,6 -120.24% | 341 121 180.9% | -508 | 247 | 316 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -226 -192 -17.8% | -87,0 -73,6 -18.11% | 267 30,5 776.13% | -582 | 180 | 246 |
|
Net income Million USD | Released Forecast Spread | -227 -193 -17.14% | -88,9 -74,7 -19.06% | 264 32,1 721.69% | -582 | 181 | 248 |
|
EPS USD | Released Forecast Spread | -1,18 -1,06 -11.81% | -0,43 -0,35 -21.82% | 1,21 0,14 764.29% | -2,31 | 0,66 | 0,76 |
| Announcement Date | 26/02/24 | 24/02/25 | 26/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 132 130 1.14% | 146 128 13.89% | 163 150 9.03% | 159 163 -2.2% | 407 151 168.67% | 156 151 3.5% | 218 183 19.05% | 166 | 170 | 167 | 190 | 195 | 393 |
|
EBITDA Million USD | Released Forecast Spread | -4,20 9,00 -146.66% | 21,6 7,00 207.97% | 30,1 22,3 35.17% | 29,9 43,0 -30.4% | -701 10,7 -6648.28% | 99,0 24,6 302.62% | 38,7 | 26,0 | |||||
|
EBIT Million USD | Released Forecast Spread | -4,51 10,2 -144.36% | 21,2 7,26 192.25% | 29,8 25,3 17.68% | 29,6 30,9 -4.26% | 260 23,2 1022.23% | -702 19,3 -3734.68% | 98,5 45,3 117.4% | 44,9 | 49,0 | 41,2 | 65,8 | 80,0 | 85,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,0 -12,9 -102.17% | 0,76 -14,7 105.16% | 6,49 5,75 12.8% | 12,1 15,1 -19.62% | 248 10,5 2266.44% | -721 7,16 -10166.69% | 79,5 25,4 213.13% | 21,1 | 24,4 | 24,4 | 49,2 | 63,8 | 69,4 |
|
Net income Million USD | Released Forecast Spread | -26,8 -12,7 -111.05% | 0,03 -15,0 100.21% | 5,09 3,97 27.94% | 12,9 9,48 36.03% | 246 11,6 2015.9% | -722 12,1 -6042.05% | 78,4 31,5 149.2% | 22,6 | 28,5 | 21,1 | 37,4 | 44,4 | 48,1 |
|
EPS USD | Released Forecast Spread | -0,13 -0,05 -137.49% | 0,00 -0,06 - | 0,02 0,02 18.34% | 0,06 0,05 14.7% | 1,12 0,05 2205.95% | -2,98 0,05 -5830.77% | 0,30 0,12 152.23% | 0,08 | 0,11 | 0,12 | 0,19 | 0,21 | 0,22 |
| Announcement Date | 24/02/25 | 05/05/25 | 04/08/25 | 03/11/25 | 26/02/26 | 06/05/26 | 05/08/26 | - | - | - | - | - | - |
| 2026-10-21 |  | Information meeting | 09:00 |
| 2026-10-22 | | Earnings release - Q3 2026 | |
| 2026-10-22 | | Earnings presentation | 08:30 |
| 2026-10-23 | | Extraordinary General Meeting | 02:00 |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-26 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-27 | | Earnings release - Q3 2026 |
Past sector events for BioCryst Pharmaceuticals, Inc.
| 2026-10-14 | | Information meeting | 14:30 |
| Today | | Présentation aux Actionnaires / Analystes | |
| Today | | Sales and Revenue Release - Q3 2026 | |
| 2026-10-14 | | Information meeting | 08:00 |
| 2026-10-13 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-13 | | Information meeting | 16:30 |
| 2026-10-13 | | Extraordinary General Meeting | 22:00 |
| 2026-10-07 | | Extraordinary General Meeting | 09:00 |
| 2026-10-07 | | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-10-06 | | Information meeting | 10:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BCRX Stock
- Calendar BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
